MedPath

The effect of melatonin in patients with polycystic ovary syndrom

Phase 3
Recruiting
Conditions
Poly Cystic Ovary Syndrome.
Poly cystic ovarian syndrome
E28.2
Registration Number
IRCT20160717028967N10
Lead Sponsor
Vice chancellor for research, Avicenna infertility center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
72
Inclusion Criteria

Age between 20 to 40 years old
Having symptoms of polycystic ovary syndrome
candidate of micro-injection for infertility treatment

Exclusion Criteria

Azospermia in sperm analysis of male partner
The use of alternative infertility treatment services
Uncontrolled medical condition
Abnormal karyotype
Uterine abnormal anatomy
Immune and coagulation dysfunction

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath